policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
JAVMA news
Vaccine holds promise for treating osteosarcoma in dogs
Veterinarians in the audience wanted to know when they could get their hands on the new treatment. Dr. Sue Ettinger, a veterinary oncologist, had…
JAVMA news
FDA extends call for treatment limit ideas
Food and Drug Administration authorities have extended a call for ideas on how to limit durations of some approved antimicrobial treatments in…
JAVMA news
Researchers hope for blood-based canine cancer test in 2020
Company backing the technology struggles amid push for test validation
JAVMA news
Searching for self-replicating antimicrobials
Viruses could supplement antimicrobials, if usefulness proved
JAVMA news
The hidden ecosystem of the gut microbiome
Millions of bacteria live in the gastrointestinal tract of animals, including cats, dogs, and humans.
JAVMA news
In Short
Osteosarcoma is genetically similar in dogs and human children, according to a study published July 19 in the journal Communications Biology by Tufts…
JAVMA news
New listings in AVMA Animal Health Studies Database
Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database.
JAVMA news
The continuing conundrum of feline injection-site sarcomas
Veterinarians would much rather talk with cat owners about all the advantages of vaccination for cats rather than the extremely rare occurrence of…